{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:47:08Z","timestamp":1775634428851,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1285,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Funds of China","doi-asserted-by":"crossref","award":["No:81270626"],"award-info":[{"award-number":["No:81270626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.exphem.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T01:22:55Z","timestamp":1536456175000},"page":"66-79.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Upregulated microRNA-146a expression induced by granulocyte colony-stimulating factor enhanced low-dosage chemotherapy response in aged acute myeloid leukemia patients"],"prefix":"10.1016","volume":"68","author":[{"given":"Xin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingyu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2018.09.002_bib0001","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3109\/10428194.2011.576791","article-title":"Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression","volume":"52","author":"Hao","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2018.09.002_bib0002","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00277-017-3150-3","article-title":"German-Austrian AML Study Group (AMLSG). Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)","volume":"96","author":"Nagel","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2018.09.002_bib0003","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","article-title":"Age and acute myeloid leukemia","volume":"107","author":"Appelbaum","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.09.002_bib0004","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.09.002_bib0005","first-page":"71","article-title":"CAG-GO therapy for patients with relapsed or primary refractory CD33-positive acute myelogenous leukemia","volume":"53","author":"Takahashi","year":"2012","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.exphem.2018.09.002_bib0006","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/leu.2017.50","article-title":"MicroRNA-155 promotes G-CSF-induced mobilization of murine hematopoietic stem and progenitor cells via propagation of CXCL12 signaling","volume":"31","author":"Itkin","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.09.002_bib0007","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3324\/haematol.2013.086959","article-title":"Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors","volume":"99","author":"B\u00e1ez","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2018.09.002_bib0008","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognosis marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.09.002_bib0009","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.09.002_bib0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1200\/JCO.2010.31.0904","article-title":"Leukemia stem cells and microenvironment: biology and therapeutic targeting","volume":"29","author":"Konopleva","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2018.09.002_bib0011","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbamcr.2015.08.003","article-title":"The role of microenvironment and immunity in drug response in leukemia","volume":"1863","author":"Bakker","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.exphem.2018.09.002_bib0012","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1607","article-title":"Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML[J]","volume":"28","author":"Saito","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2018.09.002_bib0013","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2018.09.002_bib0014","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognostic marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.09.002_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/leu.2008.299","article-title":"CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers","volume":"23","author":"Burger","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.09.002_bib0016","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.onc.1204057","article-title":"Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis","volume":"20","author":"Imai","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2018.09.002_bib0017","doi-asserted-by":"crossref","first-page":"e62785","DOI":"10.1371\/journal.pone.0062785","article-title":"TGF-beta-Neutralizing anti-body 1D11 enhances cytarabine-induced apoptosis in AML cells in the bone marrow microenvironment","volume":"8","author":"Tabe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2018.09.002_bib0018","first-page":"1","article-title":"Targeting the bone marrow microenvironment in acute leukemia","volume":"12","author":"Karantanou","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2018.09.002_bib0019","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: no place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.exphem.2018.09.002_bib0020","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1182\/blood-2010-08-301879","article-title":"Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation","volume":"117","author":"Qu\u00e9r\u00e9","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.09.002_bib0021","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1182\/blood-2010-01-234120","article-title":"G-CSF and its receptor in myeloid malignancy","volume":"115","author":"Beekman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.09.002_bib0022","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2008-10-184754","article-title":"Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization","volume":"114","author":"Christopher","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.09.002_bib0023","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12185-009-0293-6","article-title":"Modification of TGF-\u03b21 signaling pathway during NB4 cells differentiation by all-trans retinoid acid induction","volume":"89","author":"Zhong","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2018.09.002_bib0024","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1038\/bcj.2011.24","article-title":"MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias","volume":"1","author":"Spinello","year":"2011","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.exphem.2018.09.002_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.critrevonc.2015.10.001","article-title":"Constitutive NF-\u03baB activation in AML: causes and treatment strategies","volume":"98","author":"Bosman","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.exphem.2018.09.002_bib0026","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","article-title":"Nuclear factor-\u03baB is constitutively activated in primitive human acute myelogenous leukemia cells","volume":"98","author":"Guzman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.09.002_bib0027","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2018.09.002_bib0028","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.humpath.2003.08.020","article-title":"Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia","volume":"35","author":"Bueso-Ramos","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.exphem.2018.09.002_bib0029","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bjh.12725","article-title":"Advances in understanding the leukaemia microenvironment","volume":"164","author":"Tabe","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2018.09.002_bib0030","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/leu.2009.175","article-title":"Contribution of bone microenvironment to leukemogenesis and leukemia progression","volume":"23","author":"Ayala","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.09.002_bib0031","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11899-015-0255-4","article-title":"Targeting the microenvironment in acute myeloid leukemia","volume":"10","author":"Rashidi","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.exphem.2018.09.002_bib0032","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1182\/blood-2008-06-162123","article-title":"Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100","volume":"113","author":"Nervi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.09.002_bib0033","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1182\/blood-2008-05-158311","article-title":"Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML","volume":"113","author":"Zeng","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.09.002_bib0034","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1182\/blood-2004-02-0566","article-title":"Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia","volume":"104","author":"Rombouts","year":"2004","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18307999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18307999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:33:08Z","timestamp":1759566788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X18307999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":34,"alternative-id":["S0301472X18307999"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2018.09.002","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulated microRNA-146a expression induced by granulocyte colony-stimulating factor enhanced low-dosage chemotherapy response in aged acute myeloid leukemia patients","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of ISEH -- Society for Hematology and Stem Cells.","name":"copyright","label":"Copyright"}]}}